Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E J Read

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Cytotherapy|February 6, 2003
Catastrophic failures of freezing bags for cellular therapy products: description, cause, and consequencesH M Khuu, H Cowley, V David-Ocampo, et al.
Cytotherapy|December 11, 2002
Optimized clinical-scale culture conditions for ex vivo selective depletion of host-reactive donor lymphocytes: a strategy for GvHD prophylaxis in allogeneic PBSC transplantationS R Solomon, T Tran, C S Carter, et al.
British Journal of Haematology|November 11, 1999
Human G-CSF-mobilized CD34-positive peripheral blood progenitor cells can stimulate allogeneic T-cell responses: implications for graft rejection in mismatched transplantationF van Rhee, Y Z Jiang, F Vigue, et al.
Blood|July 11, 2000
Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adultsC L Mackall, D Stein, T A Fleisher, et al.
Cytotherapy|June 25, 2008
A multicenter comparison study between the Endosafe PTS rapid-release testing system and traditional methods for detecting endotoxin in cell-therapy productsA P Gee, D Sumstad, J Stanson, et al.
The New England Journal of Medicine|March 22, 2001
Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograftM E Horwitz, A J Barrett, M R Brown, et al.
Nature Medicine|October 18, 2005
Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cellsHua Zhang, Kevin S Chua, Martin Guimond, et al.
Blood|June 25, 1999
Engraftment of MDR1 and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapyJ A Moscow, H Huang, C Carter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patientsK H Cowan, J A Moscow, H Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 1997
Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous diseaseH L Malech, P B Maples, N Whiting-Theobald, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Cytotherapy|February 6, 2003
Catastrophic failures of freezing bags for cellular therapy products: description, cause, and consequencesH M Khuu, H Cowley, V David-Ocampo, et al.
Cytotherapy|December 11, 2002
Optimized clinical-scale culture conditions for ex vivo selective depletion of host-reactive donor lymphocytes: a strategy for GvHD prophylaxis in allogeneic PBSC transplantationS R Solomon, T Tran, C S Carter, et al.
British Journal of Haematology|November 11, 1999
Human G-CSF-mobilized CD34-positive peripheral blood progenitor cells can stimulate allogeneic T-cell responses: implications for graft rejection in mismatched transplantationF van Rhee, Y Z Jiang, F Vigue, et al.
Blood|July 11, 2000
Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adultsC L Mackall, D Stein, T A Fleisher, et al.
Cytotherapy|June 25, 2008
A multicenter comparison study between the Endosafe PTS rapid-release testing system and traditional methods for detecting endotoxin in cell-therapy productsA P Gee, D Sumstad, J Stanson, et al.
The New England Journal of Medicine|March 22, 2001
Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograftM E Horwitz, A J Barrett, M R Brown, et al.
Nature Medicine|October 18, 2005
Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cellsHua Zhang, Kevin S Chua, Martin Guimond, et al.
Blood|June 25, 1999
Engraftment of MDR1 and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapyJ A Moscow, H Huang, C Carter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patientsK H Cowan, J A Moscow, H Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 1997
Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous diseaseH L Malech, P B Maples, N Whiting-Theobald, et al.
Pageof 6